Updated safety and efficacy of selpercatinib in patients (pts) with RET-activated thyroid cancer: Data from LIBRETTO-001 Meeting Abstract


Authors: Wirth, L. J.; Subbiah, V.; Worden, F. P.; Solomon, B. J.; Robinson, B.; Hadoux, J.; Tomasini, P.; Weiler, D.; Deschler-Baier, B.; Tan, D. S. W.; Lin, Y.; Bayt, T.; Maeda, P.; Drilon, A.; Cassier, P.
Abstract Title: Updated safety and efficacy of selpercatinib in patients (pts) with RET-activated thyroid cancer: Data from LIBRETTO-001
Meeting Title: ESMO Congress 2023
Journal Title: Annals of Oncology
Volume: 34
Issue: Suppl. 2
Meeting Dates: 2023 Oct 20-24
Meeting Location: Madrid, Spain
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2023-10-01
Start Page: S1147
End Page: S1148
Language: English
ACCESSION: WOS:001087480203228
DOI: 10.1016/j.annonc.2023.09.1085
PROVIDER: wos
Notes: Meeting Abstract: 2229P -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alexander Edward Drilon
    632 Drilon